156 related articles for article (PubMed ID: 16318432)
1. Combining cancer vaccines with chemotherapy.
Chong G; Morse MA
Expert Opin Pharmacother; 2005 Dec; 6(16):2813-20. PubMed ID: 16318432
[TBL] [Abstract][Full Text] [Related]
2. The potential beneficial effects of drugs on the immune response to vaccination.
Liu WM; Dalgleish AG
Semin Oncol; 2012 Jun; 39(3):340-7. PubMed ID: 22595056
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Baxevanis CN; Perez SA; Papamichail M
Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
[TBL] [Abstract][Full Text] [Related]
4. Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer.
Kerr MD; McBride DA; Chumber AK; Shah NJ
Expert Opin Drug Discov; 2021 Jan; 16(1):89-99. PubMed ID: 32867561
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.
Ramakrishnan R; Gabrilovich DI
Cancer Immunol Immunother; 2011 Mar; 60(3):419-23. PubMed ID: 20976448
[TBL] [Abstract][Full Text] [Related]
6. Combinations of anticancer drugs and immunotherapy.
Mitchell MS
Cancer Immunol Immunother; 2003 Nov; 52(11):686-92. PubMed ID: 12942200
[TBL] [Abstract][Full Text] [Related]
7. Combined modality immunotherapy and chemotherapy: a new perspective.
Ramakrishnan R; Antonia S; Gabrilovich DI
Cancer Immunol Immunother; 2008 Oct; 57(10):1523-9. PubMed ID: 18488219
[TBL] [Abstract][Full Text] [Related]
8. How immunotherapy can enhance the response to other modalities and improve outcome and quality of life.
Liu WM; Meyer B; Dalgleish AG
J BUON; 2009 Sep; 14 Suppl 1():S103-9. PubMed ID: 19785052
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy: friend or foe to cancer vaccines?
Emens LA; Machiels JP; Reilly RT; Jaffee EM
Curr Opin Mol Ther; 2001 Feb; 3(1):77-84. PubMed ID: 11249735
[TBL] [Abstract][Full Text] [Related]
10. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
Emens LA; Middleton G
Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
[TBL] [Abstract][Full Text] [Related]
11. On combining antineoplastic drugs with tumor vaccines.
Terando A; Mulé JJ
Cancer Immunol Immunother; 2003 Nov; 52(11):680-5. PubMed ID: 12955481
[No Abstract] [Full Text] [Related]
12. The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.
Hodge JW; Ardiani A; Farsaci B; Kwilas AR; Gameiro SR
Semin Oncol; 2012 Jun; 39(3):323-39. PubMed ID: 22595055
[TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations.
Gatti-Mays ME; Redman JM; Collins JM; Bilusic M
Hum Vaccin Immunother; 2017 Nov; 13(11):2561-2574. PubMed ID: 28857666
[TBL] [Abstract][Full Text] [Related]
14. Enhancing efficacy of therapeutic vaccinations by combination with other modalities.
Gulley JL; Madan RA; Arlen PM
Vaccine; 2007 Sep; 25 Suppl 2(Suppl 2):B89-96. PubMed ID: 17573164
[TBL] [Abstract][Full Text] [Related]
15. Anticancer immunotherapy in combination with proapoptotic therapy.
Bruserud Ø; Ersvaer E; Olsnes A; Gjertsen BT
Curr Cancer Drug Targets; 2008 Dec; 8(8):666-75. PubMed ID: 19075589
[TBL] [Abstract][Full Text] [Related]
16. Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.
Zhang T; Herlyn D
Cancer Immunol Immunother; 2009 Apr; 58(4):475-92. PubMed ID: 18925393
[TBL] [Abstract][Full Text] [Related]
17. Drug Delivery for Cancer Immunotherapy and Vaccines.
Batty CJ; Tiet P; Bachelder EM; Ainslie KM
Pharm Nanotechnol; 2018; 6(4):232-244. PubMed ID: 30227827
[TBL] [Abstract][Full Text] [Related]
18. [Vaccination strategies for solid tumors--fundamentals, limitations, and recent results].
Atanackovic D
Ther Umsch; 2004 Jun; 61(6):389-96. PubMed ID: 15253165
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8
Redmond WL; Linch SN
Hum Vaccin Immunother; 2016 Oct; 12(10):2519-2522. PubMed ID: 27459422
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
